Halle 8a, Standnr. F19.5
Chemische Oberflächenmodifikation für die Mikro- und Nanotechnolgie, die auf innovative Nanobeschichtung basiert, ist die Kernkompetenz von Surfix.Surfix’s mission is to advance global health by delivering accurate, accessible, and affordable diagnostic solutions for disease detection and management, specifically in underserved Point-of-Care (POC) testing segments.
To achieve this goal, Surfix has developed a photonic diagnostics platform that delivers exceptional sensitivity, accuracy, and a broad dynamic range. This cutting-edge technology enables diagnostics with precision surpassing traditional laboratory standards – a POCT with beyond lab-level precision.
Surfix’s objective is to continuously enhance the platform, ensuring it remains easy to use while offering reliable and sensitive detection of a wide array of biomarkers. By doing so, Surfix is committed to elevating healthcare standards and making advanced diagnostics accessible globally.